Related Experiment Video

Updated: Mar 12, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K

Phytochemicals in the treatment of ovarian cancer

Juhi Rais1, Asif Jafri2, Sahabjada Siddiqui2

  • 1Department of Zoology, University of Lucknow, Lucknow, India 226007, juhirais44@gmail.com.

Frontiers in Bioscience (Elite Edition)
|November 5, 2016
PubMed

Insights

Natural compounds like flavonoids and antioxidants show promise in fighting ovarian cancer. These phytochemicals can kill cancer cells without harming healthy ones, offering potential new treatments.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Ovarian cancer is a leading cause of death among gynecologic cancers.
  • There is a need for novel therapeutic strategies for ovarian cancer treatment.

Purpose of the Study:

  • To explore the potential of natural products, specifically phytochemicals, in the treatment and prevention of ovarian cancer.
  • To review the cytotoxic effects of plant-derived compounds on ovarian cancer cells.

Main Methods:

  • Review of scientific literature on natural products and their effects on cancer cells.
  • Analysis of studies investigating phytochemicals, including flavones, flavonoids, and antioxidants.
  • Examination of in vitro and in vivo data regarding cancer cell cytotoxicity.

Main Results:

  • Phytochemicals, such as flavonoids and antioxidants, exhibit cytotoxic effects on ovarian cancer cells.
  • These compounds demonstrate selective toxicity, harming cancer cells while sparing normal cells.
  • Mechanisms of action include inhibition of cancer cell proliferation and induction of apoptosis.

Conclusions:

  • Natural products and their constituents hold significant therapeutic potential for ovarian cancer.
  • Phytochemicals can be considered as potential adjuncts to conventional ovarian cancer therapies.
  • Further research into plant-derived compounds may lead to improved cancer treatment outcomes.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

14.0K

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K